News | August 18, 2008

Dräger Fabius MRI Gets FDA Clearance For Advanced Anesthesia Technology for MRI


August 19, 2008 - Dräger Medical Inc. today said its Fabius MRI anesthesia machine received FDA clearance, and is designed specifically to meet the requirements for the magnetic resonance imaging (MRI) environment.

The Fabius MRI is designed for use with 1.5T and 3.0T MRI systems. An integrated Teslameter provides an acoustic alarm if the Fabius MRI is positioned within a field-strength greater than 40mTesla (400 Gauss).

The Fabius MRI employs the same user interface as Dräger’s Fabius GS, Fabius Tiro and Apollo machines, creating a uniform and consistent interface for the anesthesia provider wherever anesthesia is required. The size of the MRI system often requires the anesthesia provider to be outside the room or some distance away from the device during an examination. To accommodate this, the company said additional optical alarm displays (LEDs) at the top of the system provide visual indication for all alarm conditions for the safety of the patient in this specialized environment.

Dräger said the Fabius MRI has the same standards as those used in the OR application. The standard configuration includes the advanced ventilation modes (volume and pressure controlled, pressure support and SIMV) that are especially needed for the care of premature infants, newborns, and ICU patients. A high-speed piston ventilator provides controlled compliance compensation, even with the longer ventilation tubes often used in the MRI environment, providing even for the smallest infant.

Dräger also offers a range of MRI-compatible accessories, all tested and certified for use with the Fabius MRI machine.

For more information: www.draeger.com


Related Content

News | Magnetic Resonance Imaging (MRI)

February 21, 2024 — Hyperfine, Inc., a groundbreaking health technology company that has redefined brain imaging with ...

Home February 21, 2024
Home
News | Magnetic Resonance Imaging (MRI)

November 17, 2023 — Researchers from the University of Minnesota Medical School examining the cause of cardiomyopathy ...

Home November 17, 2023
Home
News | Magnetic Resonance Imaging (MRI)

June 28, 2023 — Liver disease, the UK’s third leading cause of premature death, poses a significantly greater threat to ...

Home June 28, 2023
Home
News | Magnetic Resonance Imaging (MRI)

June 20, 2023 — The US Food and Drug Administration has approved the use of iTFlow in blood flow analysis. The FDA ...

Home June 20, 2023
Home
News | Magnetic Resonance Imaging (MRI)

June 7, 2023 — GE HealthCare announced the FDA clearance and launch of Sonic DL – a state-of-the-art deep learning-based ...

Home June 07, 2023
Home
Feature | Magnetic Resonance Imaging (MRI) | By Johnson Polakkal Joseph

Magnetic resonance imaging (MRI) is a technology that has been around for more than four decades and is a staple in ...

Home May 01, 2023
Home
News | Magnetic Resonance Imaging (MRI)

April 18, 2023 — Findings from an award-winning Scientific Online Poster presented during the 2023 ARRS Annual Meeting ...

Home April 18, 2023
Home
News | Magnetic Resonance Imaging (MRI)

April 4, 2023 — Medtronic has announced the launch of MRI Care Pathway, a new system that can streamline the process of ...

Home April 04, 2023
Home
News | Magnetic Resonance Imaging (MRI)

November 17, 2022 — HeartVista, a pioneer in AI-assisted MRI solutions, and Siemens Healthineers, a global leader in ...

Home November 17, 2022
Home
News | Magnetic Resonance Imaging (MRI)

November 9, 2022 — According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR), left ...

Home November 09, 2022
Home
Subscribe Now